Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00243646 · ClinicalTrials.gov registry record · Phase 3

Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial

A Phase 3 study, sponsored by Schiffler Cancer Center.

Terminated
Registry status
Phase 3
Development phase
6
Enrollment target

NCT00243646: Clinical Trial Phase 3 study, sponsored by Schiffler Cancer Center.

NCT00243646 is a Phase 3 study that was terminated before completion, run by Schiffler Cancer Center. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00243646, a Phase 3 study, was terminated before completion, sponsored by Schiffler Cancer Center.

TERMINATED
Registry status
Phase 3
Development phase
6 participants
Enrollment target

Study Summary

Determine the role of androgen deprivation therapy in high risk patients receiving 45 Gy of pelvic radiotherapy plus a Pd-103 boost and the impact of the duration of ADT in hormonally-manipulated patients.

Interventions

  • DRUG Lupron
  • RADIATION External beam radiation
  • DRUG Casodex

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2004-08
Est. Completion 2009-07
Phase Phase 3

Sponsor

Schiffler Cancer Center

3 total trials

What the Registry Record Tells You About NCT00243646

The ClinicalTrials.gov registry entry for NCT00243646 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Schiffler Cancer Center, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Lupron is the first listed.

NCT00243646 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00243646 about?

NCT00243646 is a clinical study titled "Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial". Determine the role of androgen deprivation therapy in high risk patients receiving 45 Gy of pelvic radiotherapy plus a Pd-103 boost and the impact of the duration of ADT in hormonally-manipulated patients.

What is the current status of trial NCT00243646?

This trial is currently terminated. It is a Phase 3 study. The enrollment target is 6 participants. The study started on 2004-08. Estimated completion is 2009-07.

What interventions are being tested in trial NCT00243646?

The interventions under investigation include: Lupron (DRUG), External beam radiation (RADIATION), Casodex (DRUG).

Who is sponsoring clinical trial NCT00243646?

This trial is sponsored by Schiffler Cancer Center, which has 3 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.